Trinity Biotech recently announced the acquisition of Immco Diagnostics Inc. for $32.75 million.
Headquartered in Buffalo and employing 90 people, Immco is a diagnostic company specializing in the development, manufacture and sale of autoimmune test kits on a worldwide basis. This product line is complemented by specialized reference laboratory services in diagnostic immunology, pathology and immunogenetics, marketed to U.S.-based reference laboratories and hospitals.
Trinity officials state Immco is currently generating revenues of $12.5 million, with $8.5 million from product revenues and $4 million from laboratory revenues.
Trinity Biotech is based in Ireland, and has a Jamestown location at 2823 Girts Road.